Gilead’s Livdelzi wins FDA approval, can challenge Ocaliva dominance in primary biliary cholangitis… GlobalData Aug 23, 2024 The approval could present a major challenge to Ocaliva (obeticholic acid), which was until recently the sole approved drug for…
